[Evaluation of drug therapy based on the results of imaging].
Tetsuya
T
Suhara
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis; D026901:Membrane Transport Proteins / Q000032:analysis; D001523:Mental Disorders / Q000188:drug therapy*; D009419:Nerve Tissue Proteins / Q000032:analysis; D049268:Positron-Emission Tomography; D017448:Receptors, Dopamine D2 / Q000032:analysis; D050486:Serotonin Plasma Membrane Transport Proteins
D014150:Antipsychotic Agents; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D017448:Receptors, Dopamine D2; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins